3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine

C187H156N50O9 — CID 161276611

IUPAC3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine
SMILESCc1ccc(CNC(=O)c2nc3ccccc3nc2N)cc1.Cc1ccc2nc(C(=O)NCc3ccccc3)c(N)nc2c1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Nc1nc2ccccc2nc1-c1ncc(-c2ccccc2)o1.Nc1nc2ccccc2nc1-c1nnc(Nc2ccccc2)o1.Nc1nc2ccccc2nc1-c1noc(-c2ccccc2)n1.Nc1nc2ccccc2nc1-n1cc(-c2ccccc2)cn1.Nc1nc2ccccc2nc1-n1ccc(-c2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NC1CCCc2ccccc21
InChIInChI=1S/C19H18N4O.C17H13N5O.2C17H13N5.C17H12N4O.4C17H16N4O.C16H12N6O.C16H11N5O/c20-18-17(21-15-9-3-4-10-16(15)22-18)19(24)23-14-11-5-7-12-6-1-2-8-13(12)14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-17(21-15-9-5-4-8-14(15)20-16)22-11-13(10-19-22)12-6-2-1-3-7-12;18-16-17(20-15-9-5-4-8-14(15)19-16)22-11-10-13(21-22)12-6-2-1-3-7-12;18-16-15(20-12-8-4-5-9-13(12)21-16)17-19-10-14(22-17)11-6-2-1-3-7-11;2*1-11-5-4-6-12(9-11)10-19-17(22)15-16(18)21-14-8-3-2-7-13(14)20-15;1-11-6-8-12(9-7-11)10-19-17(22)15-16(18)21-14-5-3-2-4-13(14)20-15;1-11-7-8-13-14(9-11)21-16(18)15(20-13)17(22)19-10-12-5-3-2-4-6-12;17-14-13(19-11-8-4-5-9-12(11)20-14)15-21-22-16(23-15)18-10-6-2-1-3-7-10;17-14-13(18-11-8-4-5-9-12(11)19-14)15-20-16(22-21-15)10-6-2-1-3-7-10/h1-4,6,8-10,14H,5,7,11H2,(H2,20,22)(H,23,24);2-9H,1H3,(H2,18,20);1-11H,(H2,18,20);1-11H,(H2,18,19);1-10H,(H2,18,21);4*2-9H,10H2,1H3,(H2,18,21)(H,19,22);1-9H,(H2,17,20)(H,18,22);1-9H,(H2,17,19)
InChIKeyVENCCCWGLXPEAV-UHFFFAOYSA-N
MW3247.65 g/mol
LogP31.66
Rot. Bonds27

About 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine

3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine (PubChem CID 161276611) has the molecular formula C187H156N50O9 and a molecular weight of 3247.65 g/mol. Its IUPAC name is 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine.

Molecular Properties

Compound Name3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine
PubChem CID161276611
Molecular FormulaC187H156N50O9
Molecular Weight3247.65 g/mol
Exact Mass3245.33
IUPAC Name3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine
SMILESCc1ccc(CNC(=O)c2nc3ccccc3nc2N)cc1.Cc1ccc2nc(C(=O)NCc3ccccc3)c(N)nc2c1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Nc1nc2ccccc2nc1-c1ncc(-c2ccccc2)o1.Nc1nc2ccccc2nc1-c1nnc(Nc2ccccc2)o1.Nc1nc2ccccc2nc1-c1noc(-c2ccccc2)n1.Nc1nc2ccccc2nc1-n1cc(-c2ccccc2)cn1.Nc1nc2ccccc2nc1-n1ccc(-c2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NC1CCCc2ccccc21
InChIInChI=1S/C19H18N4O.C17H13N5O.2C17H13N5.C17H12N4O.4C17H16N4O.C16H12N6O.C16H11N5O/c20-18-17(21-15-9-3-4-10-16(15)22-18)19(24)23-14-11-5-7-12-6-1-2-8-13(12)14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-17(21-15-9-5-4-8-14(15)20-16)22-11-13(10-19-22)12-6-2-1-3-7-12;18-16-17(20-15-9-5-4-8-14(15)19-16)22-11-10-13(21-22)12-6-2-1-3-7-12;18-16-15(20-12-8-4-5-9-13(12)21-16)17-19-10-14(22-17)11-6-2-1-3-7-11;2*1-11-5-4-6-12(9-11)10-19-17(22)15-16(18)21-14-8-3-2-7-13(14)20-15;1-11-6-8-12(9-7-11)10-19-17(22)15-16(18)21-14-5-3-2-4-13(14)20-15;1-11-7-8-13-14(9-11)21-16(18)15(20-13)17(22)19-10-12-5-3-2-4-6-12;17-14-13(19-11-8-4-5-9-12(11)20-14)15-21-22-16(23-15)18-10-6-2-1-3-7-10;17-14-13(18-11-8-4-5-9-12(11)19-14)15-20-16(22-21-15)10-6-2-1-3-7-10/h1-4,6,8-10,14H,5,7,11H2,(H2,20,22)(H,23,24);2-9H,1H3,(H2,18,20);1-11H,(H2,18,20);1-11H,(H2,18,19);1-10H,(H2,18,21);4*2-9H,10H2,1H3,(H2,18,21)(H,19,22);1-9H,(H2,17,20)(H,18,22);1-9H,(H2,17,19)
InChIKeyVENCCCWGLXPEAV-UHFFFAOYSA-N
XLogP31.66
TPSA905.76 Ų
H-Bond Donors17
H-Bond Acceptors54
Rotatable Bonds27
Heavy Atoms246
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003247.65
LogP ≤ 531.66
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1054

Analyze 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

1-N-(5-cinnolin-6-yl-1,3-oxazol-2-yl)-3-N-(methyl-methylidene-oxo-lambda6-sulfanyl)benzene-1,3-diamine;6-[2-[3-[(methyl-methylidene-oxo-lambda6-sulfanyl)amino]anilino]-1,3-oxazol-5-yl]-2H-isoquinolin-1-one;3-N-(methyl-methylidene-oxo-lambda6-sulfanyl)-1-N-(5-phthalazin-6-yl-1,3-oxazol-2-yl)benzene-1,3-diamine;3-N-(methyl-methylidene-oxo-lambda6-sulfanyl)-1-N-(5-quinazolin-7-yl-1,3-oxazol-2-yl)benzene-1,3-diamine;3-N-(methyl-methylidene-oxo-lambda6-sulfanyl)-1-N-(5-quinoxalin-6-yl-1,3-oxazol-2-yl)benzene-1,3-diamine
CID 157095144
1-tert-butyl-2-propan-2-ylbenzene;1,3-diethyl-2-propan-2-ylbenzene;1-ethyl-3-methyl-2-propan-2-ylbenzene;N'-[(4-propan-2-ylphenyl)methyl]ethanimidamide;N-[(4-propan-2-ylphenyl)methyl]prop-1-en-2-amine;N'-[[5-(3-propan-2-ylphenyl)-1,3-oxazol-2-yl]methyl]ethanimidamide;2-propan-2-ylpyrazine;3-propan-2-ylpyridazine;4-propan-2-ylpyridazine;3-propan-2-ylpyridine;2-propan-2-ylpyrimidine;4-propan-2-ylpyrimidine;5-propan-2-ylpyrimidine;5-propan-2-ylquinoxaline;1,2,3-tri(propan-2-yl)benzene
CID 157272822
1,5-dimethylindazole;1,6-dimethylindazole;1,5-dimethylindole;2,5-dimethyl-3H-isoindol-1-one;ethane;5-methyl-1,2-benzoxazole;5-methyl-1,3-benzoxazole;6-methyl-1,3-benzoxazole;6-methylcinnoline;7-methylisoquinoline;2-methylnaphthalene;6-methylphthalazine;6-methylquinazoline;6-methylquinoline;6-methylquinoxaline
CID 157277947
1-cyclobutyl-5-(4-propan-2-yl-2-pyridinyl)indazole;1,3-dimethyl-5-(4-propan-2-yl-2-pyridinyl)benzimidazol-2-one;1,2-dimethyl-6-(4-propan-2-yl-2-pyridinyl)indazol-3-one;1-(1-methylindazol-5-yl)-3-propan-2-ylpyridin-2-one;1-methyl-3-(1-methylpiperidin-4-yl)-5-propan-2-ylbenzimidazol-2-one;1-methyl-5-(4-propan-2-yl-2-pyridinyl)pyrazolo[4,5-b]pyridine;1-(4-propan-2-yl-2-pyridinyl)indazole;2-(4-propan-2-yl-2-pyridinyl)-2,6-naphthyridin-1-one;7-(4-propan-2-yl-2-pyridinyl)-1,7-naphthyridin-8-one;7-(4-propan-2-yl-2-pyridinyl)-4H-pyrido[3,2-b][1,4]oxazin-3-one
CID 157422162
4-[(5-cyano-1,2,4-oxadiazol-3-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(5-cyano-1,3,4-oxadiazol-2-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-(5-cyano-1,2,4-oxadiazol-3-yl)-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-(5-cyano-1,3,4-oxadiazol-2-yl)-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide;4-[(2-cyano-1,3-oxazol-5-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
CID 157444891
3-Cyclopropyl-1-[3-(difluoromethyl)-2-(1,3-oxazol-2-yl)quinolin-5-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(3-methylpyrazol-1-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-5,7-dimethyl-1-[3-(3-methyl-1,2,4-triazol-1-yl)isoquinolin-8-yl]-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;3-cyclopropyl-1-[3-(3,4-dimethylpyrazol-1-yl)isoquinolin-8-yl]-5,7-dimethyl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one;1-[3-(difluoromethyl)-2-(1-methylpyrazol-4-yl)quinolin-5-yl]-5,7-dimethyl-3-piperidin-4-yl-5,8-dihydroimidazo[1,5-a]pyrazin-6-one
CID 157521346
3-[[3-[3-fluoro-3-(3-methylphenyl)cyclobutyl]-1,2,4-oxadiazol-5-yl]methyl]pyrido[2,3-d]pyrimidin-4-one;7-methyl-1-[[3-[(1R,2S,5S,6R)-2-methyl-3-(3-methylphenyl)-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one;7-methyl-1-[[3-[(1R,5S)-3-[3-(1-methylpyrrol-3-yl)phenyl]-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one;7-methyl-1-[[3-[(1R,5S)-3-[3-(1,3-oxazol-5-yl)phenyl]-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one;7-methyl-1-[[3-[(1S,5R)-3-(3-phenylphenyl)-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one;7-methyl-1-[[3-[(1S,5R)-3-(3-pyrazol-1-ylphenyl)-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one;7-methyl-1-[[3-[(1S,5R)-3-(3-pyridin-4-ylphenyl)-3-azabicyclo[3.1.0]hexan-6-yl]-1,2,4-oxadiazol-5-yl]methyl]purin-6-one
CID 157551746
6-cyano-N-[[3-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)carbamoyl]phenyl]methyl]imidazo[1,2-a]pyridine-2-carboxamide;6-cyano-N-[[3-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)carbamoyl]phenyl]methyl]-1H-indole-2-carboxamide;2-N-[[3-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)carbamoyl]phenyl]methyl]imidazo[1,2-a]pyridine-2,7-dicarboxamide;2-N-[[3-[(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)carbamoyl]phenyl]methyl]-1H-indole-2,6-dicarboxamide;N-(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[[[4-(1,3-oxazol-5-yl)benzoyl]amino]methyl]benzamide;N-(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[[[3-(1H-pyrazol-5-yl)benzoyl]amino]methyl]benzamide;N-(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[[(3-pyridin-3-ylbenzoyl)amino]methyl]benzamide;N-(2-methyl-3,4-dihydro-1H-isoquinolin-7-yl)-3-[[(4-pyridin-3-ylbenzoyl)amino]methyl]benzamide
CID 157857870
4-[5-(1-aminoisoquinolin-4-yl)-2-pyridinyl]-N'-hydroxybenzenecarboximidamide;4-[3-(8-amino-1,7-naphthyridin-5-yl)-1,2,4-oxadiazol-5-yl]-N'-hydroxybenzenecarboximidamide;4-[5-(8-amino-1,7-naphthyridin-5-yl)-1,3,4-oxadiazol-2-yl]-N'-hydroxybenzenecarboximidamide;4-[5-(8-amino-1,7-naphthyridin-5-yl)-1,3-oxazol-2-yl]-N'-hydroxybenzenecarboximidamide;4-[2-(8-amino-1,7-naphthyridin-5-yl)-1,3-thiazol-4-yl]-N'-hydroxybenzenecarboximidamide;4-[1-(2-aminoquinolin-4-yl)pyrazol-3-yl]-N'-hydroxybenzenecarboximidamide
CID 158022304
5-cinnolin-6-yl-6-phenylpyrazin-2-amine;N-(5-cinnolin-6-yl-6-phenylpyrazin-2-yl)acetamide;5-isoquinolin-6-yl-6-phenylpyrazin-2-amine;3-methyl-5-(3-methylbenzimidazol-5-yl)-6-phenylpyrazin-2-amine;5-(2-methylquinolin-6-yl)-6-phenylpyrazin-2-amine;6-(1,3-oxazol-2-yl)-5-quinolin-6-ylpyrazin-2-amine
CID 158347035
3-amino-N-benzylquinoxaline-2-carboxamide;3-amino-N-[[3-(dimethylamino)phenyl]methyl]quinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-(1-phenylethyl)quinoxaline-2-carboxamide;3-[5-(2-aminophenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;bis(3-(5-methyl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine);3-[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-pyridin-3-yl-1,3,4-oxadiazol-2-yl)quinoxalin-2-amine
CID 158428423
1-[6-[1-(cyclopropylmethyl)-2-oxo-4-pyridinyl]-4-pyrazol-1-yl-1H-benzimidazol-2-yl]-3-ethylurea;1-ethyl-3-[6-[1-(2-methoxyethyl)-2-oxo-4-pyridinyl]-4-pyrazol-1-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-pyridin-3-yl-1H-benzimidazol-2-yl]urea;1-ethyl-3-[4-(5-methyl-1,3-oxazol-2-yl)-6-pyridin-3-yl-1H-benzimidazol-2-yl]urea
CID 158461219

Frequently Asked Questions

What is the IUPAC name of 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine?
The IUPAC name of 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine (CID 161276611) is 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine.
What is the SMILES notation for 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine?
The canonical SMILES for 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine is Cc1ccc(CNC(=O)c2nc3ccccc3nc2N)cc1.Cc1ccc2nc(C(=O)NCc3ccccc3)c(N)nc2c1.Cc1cccc(-c2nnc(-c3nc4ccccc4nc3N)o2)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Cc1cccc(CNC(=O)c2nc3ccccc3nc2N)c1.Nc1nc2ccccc2nc1-c1ncc(-c2ccccc2)o1.Nc1nc2ccccc2nc1-c1nnc(Nc2ccccc2)o1.Nc1nc2ccccc2nc1-c1noc(-c2ccccc2)n1.Nc1nc2ccccc2nc1-n1cc(-c2ccccc2)cn1.Nc1nc2ccccc2nc1-n1ccc(-c2ccccc2)n1.Nc1nc2ccccc2nc1C(=O)NC1CCCc2ccccc21.
What is the InChIKey of 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine?
The InChIKey is VENCCCWGLXPEAV-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H18N4O.C17H13N5O.2C17H13N5.C17H12N4O.4C17H16N4O.C16H12N6O.C16H11N5O/c20-18-17(21-15-9-3-4-10-16(15)22-18)19(24)23-14-11-5-7-12-6-1-2-8-13(12)14;1-10-5-4-6-11(9-10)16-21-22-17(23-16)14-15(18)20-13-8-3-2-7-12(13)19-14;18-16-17(21-15-9-5-4-8-14(15)20-16)22-11-13(10-19-22)12-6-2-1-3-7-12;18-16-17(20-15-9-5-4-8-14(15)19-16)22-11-10-13(21-22)12-6-2-1-3-7-12;18-16-15(20-12-8-4-5-9-13(12)21-16)17-19-10-14(22-17)11-6-2-1-3-7-11;2*1-11-5-4-6-12(9-11)10-19-17(22)15-16(18)21-14-8-3-2-7-13(14)20-15;1-11-6-8-12(9-7-11)10-19-17(22)15-16(18)21-14-5-3-2-4-13(14)20-15;1-11-7-8-13-14(9-11)21-16(18)15(20-13)17(22)19-10-12-5-3-2-4-6-12;17-14-13(19-11-8-4-5-9-12(11)20-14)15-21-22-16(23-15)18-10-6-2-1-3-7-10;17-14-13(18-11-8-4-5-9-12(11)19-14)15-20-16(22-21-15)10-6-2-1-3-7-10/h1-4,6,8-10,14H,5,7,11H2,(H2,20,22)(H,23,24);2-9H,1H3,(H2,18,20);1-11H,(H2,18,20);1-11H,(H2,18,19);1-10H,(H2,18,21);4*2-9H,10H2,1H3,(H2,18,21)(H,19,22);1-9H,(H2,17,20)(H,18,22);1-9H,(H2,17,19).
What are the key properties of 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine?
3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine has a molecular weight of 3247.65 g/mol, XLogP of 31.66, 27 rotatable bonds, 17 hydrogen bond donors, and 54 hydrogen bond acceptors.
Where does this data come from?
All data for 3-amino-N-benzyl-6-methylquinoxaline-2-carboxamide;bis(3-amino-N-[(3-methylphenyl)methyl]quinoxaline-2-carboxamide);3-amino-N-[(4-methylphenyl)methyl]quinoxaline-2-carboxamide;5-(3-aminoquinoxalin-2-yl)-N-phenyl-1,3,4-oxadiazol-2-amine;3-amino-N-(1,2,3,4-tetrahydronaphthalen-1-yl)quinoxaline-2-carboxamide;3-[5-(3-methylphenyl)-1,3,4-oxadiazol-2-yl]quinoxalin-2-amine;3-(5-phenyl-1,2,4-oxadiazol-3-yl)quinoxalin-2-amine;3-(5-phenyl-1,3-oxazol-2-yl)quinoxalin-2-amine;3-(3-phenylpyrazol-1-yl)quinoxalin-2-amine;3-(4-phenylpyrazol-1-yl)quinoxalin-2-amine is sourced from PubChem (CID 161276611), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).